News
Tuesday 29th November 2011
ECS acts for NuCana BioMed Limited in $10.4 Million Series A Financing
Friday 9th September 2011
Panoramic Growth Equity invest in Solfex Limited
Solfex, which is one of the UK’s leading distributors of solar energy systems, has secured £1.25m in funding from Panoramic Growth Equity. Solfex distributes state-of-the-art solar thermal (water heating) and solar photovoltaic systems. It has developed a reputation for excellence in its dealings with leading European suppliers and a client base spread throughout the UK.
Thursday 30th June 2011
E-Land Group acquire Lochcarron John Buchan Limited
ECS acts for the owners of Scottish Borders knitwear company Lochcarron John Buchan Limited in its sale to South Korean retail conglomerate E-Land Group.
Tuesday 15th March 2011
ECS acts in MBO of David Philp (Commercials) Ltd
ECS acts for the management team in the MBO of David Philp (Commercials) Ltd
Monday 25th January 2010
Amati Global Partners LLP acquires Noble Fund Managers Limited
Amati Global Partners LLP, a new entity formed by Paul Jourdan and Douglas Lawson, who between them manage the investments of Noble AIM VCT on behalf of Noble Fund Managers Ltd, is pleased to announce the completion of the acquisition of Noble Fund Managers Ltd.
Friday 18th December 2009
Alida Capital International completes financing into NuCana BioMed
v id="divYouTubeVideo">
Alida Capital International Ltd (“Alida”) today announced it had completed an equity financing into Edinburgh based biopharmaceutical company NuCana BioMed (“NuCana”). The Scottish Enterprise Scottish Co-Investment Fund participated in the round.
Hugh Griffith, Alida’s Chief Executive stated: “We are delighted to have completed our first investment with Scottish Enterprise’s Scottish Co-Investment Fund. NuCana offers a very attractive investment opportunity and the product portfolio has the potential to make a very real difference to the treatment of people with cancer.”
This new financing will allow NuCana to complete the core non clinical and manufacturing programmes and, importantly, enable the initiation of the first clinical studies. This announcement follows the recent statement from NuCana that it had exercised its exclusive option and acquired the exclusive world-wide licence to exploit the ProTide technology. ProTides are chemical moieties which have the unique capacity to enhance efficacy and reduce toxicity of certain well established cancer agents. NuCana, whilst driving the development and commercialisation of these new and exciting medicines, will continue the research collaboration with Cardiff University and Morvus Technologies Ltd.
About Alida Capital International Ltd
Established in 2009, Alida Capital International (ACI) is one of Scotland’s newest business angel syndicates. ACI members have considerable entrepreneurial, financial and management experience in the biopharmaceutical sector and offer a flexible approach to funding.
ACI’s investment criteria focuses specifically on biopharmaceutical companies where proof of relevance clinical data has been generated and a clear regulatory strategy identified. A strong IPR position is essential. Each investment opportunity is considered on an individual basis and on its fit with ACI’s strategy. About NuCana BioMed Ltd NuCana BioMed is an emerging biopharmaceutical company dedicated to the discovery, development and commercialisation of innovative, rationally designed medicines that address significant unmet medical needs. The NuCana BioMed management team has a successful track record of building virtual biopharmaceutical organisations to global integrated companies.
About Scottish Enterprise
Scottish Enterprise is Scotland’s main enterprise, innovation and investment agency. Working in partnership with industry, academia and the public sector, SE aims to help make Scotland a place where business can thrive and key industries can be competitive. Its focus is to help businesses grow, encourage greater innovation and create the right conditions for companies to access property, markets and finance to increase productivity and increase Scotland’s ability to compete internationally.
The Scottish Co-investment Fund (SCF) is a £72 million equity investment fund established by Scottish Enterprise, and partly funded by the European Regional Development Fund (ERDF), to invest from £100,000 to £1 million in company finance deals of up to £2 million.
Monday 7th December 2009
Roden now on the acquisition trail after departure from Patisserie UK
Lees Foods public limited company purchased Patisserie UK in 2007. The takeover was concluded on both sides in good faith at an agreed market value. However, due to unforeseen circumstances anticipated sales did not materialise as originally forecast leading to a dispute. Following a constructive process of discussion an amicable settlement has been reached with no admission of liability on either side.
Wednesday 18th November 2009
Nucana Biomed signs an exclusive, world-wide, licence to develop its ProTide technology in cancer
NuCana BioMed Ltd ("NuCana") and Morvus Technology Ltd ("Morvus") today announce that an agreement has been signed by which Morvus has granted to NuCana an exclusive, world-wide, licence with rights to develop its ProTide technology for the enhancement of nucleoside analogues ("nucleosides"). These are important drugs used in the treatment of many common cancers and in 2008 the top-selling drug of this type, Gemzar® (gemcitabine: Eli Lilly) had world-wide sales of over $1.7billion.
Friday 17th July 2009
Hardide plc Investment by Noble AIM VCT plc
ECS acts for Noble AIM VCT plc in a £2.5m equity investment round in Hardide plc
Wednesday 1st July 2009
Investment in NXVision Limited
ECS acts for NXVision Limited in the investment in that company by its management team, Braveheart, Scottish Enterprise and LINC Scotland
Friday 19th June 2009
International Investor Syndicate formed: Alida Capital International
ECS acts in the formation of Alida Capital International Limited, a new angel syndicate which has acquired Scottish Co-investment Fund Partnership status. Further details of the syndicate can be found at www.alidacapital.com
Friday 29th May 2009
MBO of Scottish Slimmers business
ECS acts for the management team in the MBO of the Scottish Slimmers business
Thursday 26th February 2009
Deltex Medical Group plc investment by Noble AIM VCT plc
ECS acts for Noble AIM VCT plc in their investment in Deltex Medical Group plc
Wednesday 25th February 2009
RailSimulator.com Limited
ECS acts for RailSimulator.com Limited in a significant equity investment in the company and its first acquisiton
Monday 2nd February 2009
Client wins Land Court review of interpretation of European legislation
In an interesting departure from our usual work we were delighted to assist a client on his successful challenge in the Land Court to the Scottish Ministers interpretation of European legislation
Tuesday 23rd December 2008
investment in Antoxis Limited by Kapital
ECS act for Kapital Venture Equity LLP in leading the syndicated round of investment in Antoxis Limited
Monday 8th December 2008
Nailing another deal down; The Dundee Nail Company Ltd
ECS acts for The Dundee Nail Company Ltd in the purchase of the business and assets of Scotlands largest independent industrial fasteners business
Monday 1st December 2008
StatoilHydro Equity Assets Reorganisation
ECS acts fior StatoilHydro Ventures AS in the reorganisation of its UK investments
Friday 1st August 2008
£130m aggregate deal value in last 12 Months
ECS completes £5m investment for Saudi investors taking ECS’s aggregate deal value to in excess of £130m in the last 12 months.
Tuesday 1st July 2008
ECS acts for AGR Group ASA in £20m acquisition
ECS acts for AGR Group ASA, which acquired TRACS International Consultancy Ltd, a leading worldwide provider of integrated services and training within geology and petroleum engineering with offices in Aberdeen, London and Moscow, for £20million.
Tuesday 1st July 2008
ECS acts for vendors in sale of Caltech Holdings Ltd
ECS acts for the vendors in the sale of Caltech Holdings Limited to Veolia Environmental, the leading environmental services business in the world.
Friday 11th April 2008
investment in Immunosolv Limited by Grampian Bio Partners
ECS acts for Grampian Bio Partners in their investment in Immunosolv Limited
Monday 31st December 2007
Dundas Chemicals acquires Wm Forrest business
ECS acts for Dundas Chemical Company (Mosspark) Limited in its strategic acquisiton of the rendering business and assets of Wm Forrest
Monday 3rd December 2007
Lees buys Rock Cake Limited for £2.45m
Lees Foods plc has acquired Rock Cake Limited and its trading arm Patisserie UK Limited, a speciality bakery and dessert manufacturer for an aggregate consideration of £2.45 million.
Patisserie UK is the trading arm of Rock Cake Ltd and is based in Livingston,Scotland. It is an innovative manufacturer of speciality bakery and desserts,and employs a total of 50 people, including a professional team of skilled bakers and pastry chefs. Patisserie UK supplies the local out-of-home market including coffee chains, hotels and restaurants, travel and contract catering outlets.
Patisserie UK was created as a result of a management buy-out in February 2006 from Enterprise Foods in which ECS acted for the management.
